BUY109NVO@$47.45
- Notional
- $5,172.19
- Order type
- Limit at $47.50
- NVO now
- $39.71Sep 21, 1:39 PM ET
- Since this trade
- −16.32%
NVO top-up at marketable limit, six days after the original 46.08 limit failed to catch. Stock has been quiet in the 46-48 range and the metabolic/GLP-1 leg of the basket needs filling. 109 shares at 47.50 sizes to ~5% of book, the original target weight for the next-gen-metabolic anchor. Replacing untradeable VKTX with NVO was the right call: Ozempic/Wegovy is the visible compounder while the smaller GLP-1 names re-rate.